Matthew T Roe Selected Research

Matthew T Roe Research Topics

Disease

124	Acute Coronary Syndrome 01/2022 - 01/2002
97	ST Elevation Myocardial Infarction 03/2021 - 09/2002
86	Myocardial Infarction 11/2023 - 02/2002
83	Hemorrhage 02/2024 - 12/2002
41	Non-ST Elevated Myocardial Infarction 03/2021 - 01/2002
39	Unstable Angina 01/2020 - 01/2002
36	Stroke (Strokes) 11/2023 - 12/2002
33	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 11/2002
20	Heart Failure 12/2020 - 03/2005
15	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023 - 09/2006
12	Diabetes Mellitus 09/2023 - 05/2004
11	Thrombosis (Thrombus) 01/2020 - 03/2005
10	Chronic Renal Insufficiency 12/2018 - 03/2006
9	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2002
9	Infarction (Infarctions) 12/2018 - 12/2003
7	Ischemic Stroke 01/2020 - 04/2016
7	Cardiogenic Shock 02/2016 - 11/2005
6	Chest Pain (Chest Pains) 12/2018 - 08/2002
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 08/2002
6	Shock 11/2013 - 06/2010
5	Atrial Fibrillation 12/2019 - 11/2013
5	Neoplasms (Cancer) 10/2019 - 07/2010
5	Hypertension (High Blood Pressure) 06/2015 - 07/2006
4	Ischemia 01/2020 - 02/2002
4	Peripheral Arterial Disease 01/2020 - 01/2011
4	Body Weight (Weight, Body) 08/2013 - 06/2009
3	Gout 01/2020 - 05/2017
3	Dyslipidemias (Dyslipidemia) 12/2019 - 01/2019
3	Transient Ischemic Attack 10/2019 - 06/2015
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2019 - 03/2014
3	Heart Arrest (Cardiac Arrest) 01/2018 - 04/2014
3	Pathologic Constriction (Stenosis) 03/2016 - 08/2008
3	Renal Insufficiency (Renal Failure) 08/2014 - 09/2006
3	Necrosis 07/2012 - 04/2005
2	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 03/2020

Drug/Important Bio-Agent (IBA)

49	Clopidogrel (Plavix)FDA Link 01/2020 - 04/2006
34	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2024 - 01/2002
31	Prasugrel Hydrochloride FDA Link 01/2020 - 01/2007
21	Glycoproteins (Glycoprotein)IBA 03/2015 - 07/2003
18	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 07/2006
16	alirocumabIBA 01/2021 - 11/2014
13	TroponinIBA 01/2018 - 04/2005
12	oxidized low density lipoproteinIBA 12/2020 - 09/2009
12	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2002
12	Platelet Membrane Glycoprotein IIbIBA 12/2010 - 09/2002
11	LDL CholesterolIBA 12/2020 - 09/2009
10	CreatinineIBA 01/2018 - 03/2009
10	Heparin (Liquaemin)FDA LinkGeneric 06/2014 - 01/2002
9	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020 - 11/2013
9	Hemoglobins (Hemoglobin)IBA 04/2017 - 05/2008
9	MB Form Creatine KinaseIBA 10/2014 - 12/2003
8	Warfarin (Coumadin)FDA LinkGeneric 08/2014 - 02/2008
7	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2019
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 12/2003
7	Enoxaparin (Lovenox)FDA LinkGeneric 03/2011 - 01/2002
7	Eptifibatide (Integrilin)FDA Link 03/2008 - 12/2002
6	TicagrelorIBA 01/2020 - 06/2011
6	Fibrinolytic Agents (Antithrombotic Agents)IBA 08/2017 - 10/2005
6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2014 - 12/2002
5	pro-brain natriuretic peptide (1-76)IBA 10/2019 - 07/2012
5	HDL CholesterolIBA 11/2018 - 10/2008
5	LipidsIBA 09/2016 - 02/2005
5	AnticoagulantsIBA 04/2016 - 03/2012
4	Proprotein Convertase 9IBA 12/2020 - 11/2018
4	Creatine Kinase (Creatine Phosphokinase)IBA 10/2014 - 01/2006
4	ORALIT (ORS)IBA 05/2009 - 09/2006
4	Platelet Membrane GlycoproteinsIBA 01/2005 - 12/2002
3	apixabanIBA 01/2022 - 01/2016
3	Thrombin Receptors (Thrombin Receptor)IBA 01/2022 - 01/2016
3	Uric Acid (Urate)IBA 12/2020 - 05/2017
3	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2017
3	Lipoproteins (Lipoprotein)IBA 12/2019 - 01/2019
3	Ezetimibe (Zetia)FDA Link 01/2019 - 10/2017
3	RivaroxabanIBA 01/2019 - 04/2016
3	Troponin IIBA 02/2015 - 04/2007
3	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2013 - 12/2007
3	AntithrombinsIBA 12/2005 - 12/2003
3	Tenecteplase FDA Link 03/2005 - 04/2003
2	Leuprolide (Lupron)FDA LinkGeneric 10/2021 - 03/2020
2	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 10/2021 - 03/2020
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2021 - 03/2020
2	CholesterolIBA 12/2020 - 11/2019
2	ApolipoproteinsIBA 12/2020 - 11/2018
2	HDL LipoproteinsIBA 12/2020 - 10/2008
2	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 01/2019
2	AndrogensIBA 03/2020 - 01/2020
2	Lipoprotein(a)IBA 01/2020 - 01/2020
2	Cytochrome P-450 CYP2C19IBA 01/2019 - 03/2016

Therapy/Procedure

114	Therapeutics 03/2021 - 01/2002
84	Percutaneous Coronary Intervention 01/2020 - 12/2003
29	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 10/2005
11	Secondary Prevention 02/2024 - 01/2012
11	Stents 01/2020 - 12/2003
9	Thrombolytic Therapy 12/2017 - 12/2003
7	Drug-Eluting Stents 10/2016 - 09/2005
6	Contraindications 10/2012 - 07/2005
5	Length of Stay 11/2012 - 12/2005
4	Blood Transfusion (Blood Transfusions) 10/2023 - 10/2005
4	Erythrocyte Transfusion 05/2009 - 03/2005
3	Patient Readmission 06/2015 - 04/2012